About Invent Biomed
Invent Biomed is a Healthcare company based in Mumbai (India) founded in 2005. Manufacturer of drug eluting stents, PTCA balloon catheters, and vascular accessories. Invent Biomed has raised $1 million across 6 funding rounds from investors including Ladderup, Murgesan Madurai Veeran Devendran and Suman Manglunia. The company has 15 employees. Its Indian entity Invent Bio-Med Private Limited reported revenue of ₹20.39 Cr. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices.
Company details
Invent Biomed was founded in 2005 and is based in Mumbai, India. Operations focus on the cardiovascular medical device sector, where a range of products is manufactured, including drug eluting stents, pre-dilatation and post-dilatation PTCA balloon catheters, angiographic diagnostic catheters, guiding catheters, PTCA guide wires, introducer sheaths, and accessories such as torquers and hemostasis Y connectors. Vascular solutions are provided through these items.
- Headquarters Mumbai, India
- Employees 15
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website inventbiomed.com
- Legal Name Invent Bio-Med Private Limited
- Date of Incorporation 03 May, 2005
- Annual Revenue₹20.39 Cr
FY 2025 · +37% YoY
- Net Profit₹2.29 Cr
FY 2025 · 11% margin
- EBITDA₹4.60 Cr
FY 2025 · 23% margin
- Total Equity Funding$1M (USD)
in 6 rounds
- Latest Funding Round$43.49K (USD), Angel Round
Feb 2021
- InvestorsLadderup
& 14 more
- Employee Count15
Associated legal entities of Invent Biomed
Invent Biomed operates through Invent Bio-Med Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Invent Bio-Med Private Limited CIN U33110MH2005PTC152988 | Active | 03 May 2005 | Mumbai, Maharashtra | ₹20.4 Cr | 15 | 5 | View details |
Funding Insights of Invent Biomed
Invent Biomed has successfully raised a total of $1M across 6 strategic funding rounds. The most recent funding activity was a Angel Round of $43.49 thousand completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1M
- Total Rounds 6
- Last Round Angel Round — $43,492
- First Round $219,919
(Aug 2007)
- Investors Count 15
All 6 funding rounds of Invent Biomed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $43,492 | Angel Round | – | Murgesan Madurai Veeran Devendran | – |
| Mar 2020 | $472,813 | Angel Round | – | Suman Manglunia | |
| Jun 2010 | $236,970 | Angel Round | – | Murgesan Madurai Veeran Devendran | |
| Aug 2009 | Angel Round | – | Praful Parikh | ||
| Dec 2007 | $27,933 | Seed | – | Ladderup | – |
| Aug 2007 | $219,919 | Angel Round | – | Dwarkesh Parikh |
15 investors in total: 1 institutional and 14 angel.
Investors in Invent Biomed
Invent Biomed has secured backing from 15 investors, including angel and institutional investors. Prominent investors backing the company include Ladderup, Murgesan Madurai Veeran Devendran and Suman Manglunia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Boutique investment bank focused on middle market | 1993 | ladderup.com | Mumbai, India | |
MM Murgesan Madurai Veeran Devendran | unknown_921651d76d49401f8 | |||
SM Suman Manglunia | unknown_941319019af245219 | |||
SM Shyam Manglunia | unknown_02eb1632c1a246fea | |||
RG Rajkumar Gopilal Manglunia | unknown_a873a9124dd144e18 | |||
VO Vinay Omprakash Agarwal | unknown_b9c4f84232804450a | |||
SA Saroj Agarwal | unknown_8d1957b248604b5eb | |||
SM Sunita Manglunia | unknown_0598237aa4ae44588 | |||
ZQ Zang Qui | unknown_5de0207bea7146478 | |||
PP Praful Parikh | unknown_d63921ac4633460c8 |
Investor details for Invent Biomed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Invent Bio-Med Private Limited (Invent Biomed)
Invent Bio-Med Private Limited is the primary company behind Invent Biomed. The board of Invent Bio-Med Private Limited currently have 4 directors; the longest-serving is Rajkumar Gopilal Manglunia, appointed in 2017. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajkumar Gopilal Manglunia DIN 00248128 | Director | 08 Aug 2017 | 9 yrs 3 mo | Invent Bio-Med Private Limited |
| Ronak Manglunia DIN 07618117 | Director | 08 Aug 2017 | 9 yrs 3 mo | Invent Bio-Med Private Limited |
| Shyam Manglunia DIN 00896932 | Director | 08 Aug 2017 | 9 yrs 3 mo | Invent Bio-Med Private Limited |
| Amit Banwarilal Agrawal DIN 07587045 | Director | 16 May 2022 | 4 yrs 5 mo | Invent Bio-Med Private Limited |
Financials of Invent Biomed
Figures of Invent Bio-Med Private Limited, the primary company behind Invent Biomed, for FY 2025. Revenue was ₹20.39 Cr (+37% year on year). Net profit was ₹2.29 Cr (11% margin). EBITDA was ₹4.60 Cr (23% margin). Revenue has grown at a compounded annual rate of +90% over three years and +29% over five years.
- ₹20.39 CrRevenue · FY 2025 · +37% YoY
- ₹2.29 CrNet profit · 11% margin
- ₹4.60 CrEBITDA · 23% margin
- ₹24.70 CrPaid-up capital
- 15Employees (provident fund records)
- +90%Revenue CAGR, 3 years
- +29%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Invent Bio-Med Private Limited are on its company page.
Detailed financial statements for Invent Biomed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Invent Biomed
3 dated milestones of Invent Biomed across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Invent Biomed is founded.
- Funding First funding round of $220K.
- Funding Latest funding round, Angel Round, of $43K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Invent Biomed
Complete news archive for Invent Biomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invent Biomed
Invent Biomed was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Invent Biomed is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Invent Biomed is a funded company, having raised a total of $1M across 6 funding rounds to date. The company's 1st funding round was a Angel Round of $219.92K, raised on Aug 2007.
Invent Biomed has 15 employees.
The primary company behind Invent Biomed, Invent Bio-Med Private Limited, reported revenue of ₹20.39 Cr for FY 2025, up 37% year on year.
Invent Biomed was founded in 2005 and is based in Mumbai, India. Operations focus on the cardiovascular medical device sector, where a range of products is manufactured, including drug eluting stents, pre-dilatation and post-dilatation PTCA balloon catheters, angiographic diagnostic catheters, guiding catheters, PTCA guide wires, introducer sheaths, and accessories such as torquers and hemostasis Y connectors. Vascular solutions are provided through these items.
Invent Biomed has 15 investors. Key investors include Ladderup, Murgesan Madurai Veeran Devendran, Suman Manglunia, Shyam Manglunia, and Rajkumar Gopilal Manglunia.
Invent Biomed operates through Invent Bio-Med Private Limited.
The legal entities of Invent Biomed currently have 5 directors, including Sagar Rajvanshi, Rajkumar Gopilal Manglunia, Amit Banwarilal Agrawal and others.